University of Minnesota. Driven to Discover.
Cefiderocol has a novel way of penetrating the outer membrane of gram-negative bacteria, including resistant ones.
The new law would generally limit use of antibiotics to prevent disease in individual animals.
Bacterial reads for unexplained sepsis were 1,000 times higher than with a different assay.
Report calls for more aggressive action to reduce unnecessary antibiotic use and promote antibiotic development.
Experts hope the move will aid future antibiotic discovery.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.